MYELOFIBROSIS，MF
Clinical trials for MYELOFIBROSIS，MF explained in plain language.
Never miss a new study
Get alerted when new MYELOFIBROSIS，MF trials appear
Sign up with your email to follow new studies for MYELOFIBROSIS，MF, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough blood cancer symptoms
Disease control CompletedThis study tested whether adding a new drug called navitoclax to an existing treatment (ruxolitinib) could better control myelofibrosis, a serious bone marrow cancer. It involved 191 adults whose disease was not well-controlled on current treatments. Researchers measured if the t…
Matched conditions: MYELOFIBROSIS，MF
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New pill tested to control rare blood cancers
Disease control CompletedThis early-stage study tested a new oral drug called flonoltinib in adults with myeloproliferative neoplasms (MPNs), a group of rare bone marrow cancers. The main goals were to check the drug's safety, find the highest tolerable dose, and see how the body processes it. Researcher…
Matched conditions: MYELOFIBROSIS，MF
Phase: PHASE1, PHASE2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC